BIA-ALCL. Authors from Dana Farber, Memorial Sloan Kettering, and MD Anderson Cancer Center, all National Comprehensive Cancer Network lymphoma committee authors, present the 2019 update to the BIA-ALCL consensus guidelines. Previous recommendations are now further augmented and expanded by evidence-based interim publications. The supplement continues with the current state of research on pathogenesis by examining leading theories on the critical role of cytokines, biofilm, inflammatory mediators, superantigens, and cellular origins. Collectively, these manuscripts represent an enormous step forward in our understanding of lymphomagenesis and demonstrate progress made towards preventing the disease process. Finally, special topic manuscripts are presented by Dr. Hamdi on polyurethane implants and Dr. Deva on managing conflicts of interest in BIA-ALCL research. All supplement articles have undergone extensive and rigorous peer-review by invited content experts and the editorial board and underwent further revision before acceptance to ensure the highest quality information is presented. 
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Aesthetic Surgery Journal 39(S1) Controversies are inherently emotional and polarizing, with few debates more so in the field of plastic surgery than is generated by BIA-ALCL. However, this supplement has an important overarching theme beyond controversy, and that is one of collaboration. Although we may not be able to achieve consensus on every aspect of the disease, the authors in this supplement have demonstrated a commitment to working together, information exchange, and research partnership. I would like to thank the editorial office team and the coauthors for their contributions to the supplement under accelerated timelines, their high level of academic discourse, and their collaborative spirit. The supplement was only possible through the generous support of industry sponsors who importantly relinquished any content or editorial control. As the number one journal in aesthetic surgery, ASJ has a commitment to spreading the most critical scientific developments pertinent to plastic surgeons. We proudly present this supplement, "Current Controversies in Breast Implant-Associated Anaplastic Large Cell Lymphoma," and hope the readership finds meaningful information for their practice and for the future of research on this disease.
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